|
Anika Therapeutics (Bedford, MA, USA) celebrated 25 years of performance in 2017 with over 25 million procedures performed. The global medical technology company is at the forefront of pain management, tissue regeneration and wound healing and committed to delivering innovative medical solutions that help patients feel better faster and remain active. Anika's proprietary technology is based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body vital for proper joint health and tissue function. Some of its industry-leading partners are DePuy Synthes Mitek Sports Medicine and Medtronic. OrthoGrow is Anika's exclusive distributor for the hyaluronic acid portfolio in the BeNeLux.
|
Key products are highlighted below. For a full portfolio overview, please visit the Anika website or contact us at info@ortho-grow.com.
CINGALCINGAL is the first and only approved combination viscosupplement formulated to provide the benefit of a cross-linked hyaluronic acid (HA) and a fast acting steroid to effectively treat the symptoms associated with osteoarthritis. It is a powerful, first-in-class treatment that combines the benefits of Anika's proprietary cross-linked hyaluronic acid formulation of MONOVISC, proven to deliver up to 6 months of relief of symptoms, with a well-established FDA-approved steroid to treat inflammation and provide additional short-term pain relief. Hereby, single injection CINGAL acts both rapid and long term with a strong safety profile. Visit www.cingal.com to learn more.
|
ORTHOVISC is a non-animal sourced ultra-pure high molecular weight injectable hyaluronic acid (HA) viscosupplement used to treat the joint pain caused by osteoarthritis. It may provide up to 6 months of efficacy with only 3 to 4 injections spaced one week apart. The effectiveness of the treatment is partially based on the product's delivery of one of the highest concentrations of HA (15mg/mL) currently available in a multi-injection treatment. Visit www.orthovisc.com to learn more.
MONOVISC is the only non-animal sourced HA single injection treatment approved for use in the US, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment. With just one injection, it may provide pain relief that lasts for up to 6 months and offers better patient compliance possible. Visit www.monovisc.com to learn more.
|
